Clinicopathological Significance of Syndecan-1 in Cholangiocarcinoma: A Study Based on Immunohistochemistry and Public Sequencing Data.

Tiemo Sven Gerber Fabian BartschDaniel C WagnerMario Schindeldecker Lisa-Katharina GrögerWilfried RothHauke LangBeate Katharina Straub

Published in: Journal of clinical medicine (2021)

Syndecan-1 was found to be downregulated during cholangiocarcinogenesis, yet we could not show significant effects on prognosis on protein level. Further analyses are needed to further depict its specific role.

Keyphrases

healthcare
electronic health record
single cell
mental health
big data
protein protein
binding protein
emergency department
data analysis
deep learning